Raymond James Starts Korro Bio Inc. (KRRO) at Strong Buy

Go back to Raymond James Starts Korro Bio Inc. (KRRO) at Strong Buy

Korro Bio Inc. (KRRO) PT Raised to $105 at RBC Capital

October 21, 2024 6:45 AM EDT

RBC Capital analyst Luca Issi raised the price target on Korro Bio Inc. (NASDAQ: KRRO) to $105.00 (from $95.00) while maintaining a Outperform rating.

The analyst comments "We caught up with management and KRRO noted that WVEs data is fantastic news for the broader field, as the bear thesis (drugging ADAR wont work in humans) is officially off the table. Management... More